PPARA and Alzheimer disease: Although modifications in brain PPARA, ACOX1, CPT1A, and PDK4 expression observed could be mediated by variations in hAPP expression in AD, a role for hAPP cleavage products including Aβ, tau phosphorylation, brain inflammation, synaptic loss, and amyloid burden reported in AD brains cannot be ruled out (2).